Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
Solta Medical's novel addition to its aesthetic device solutions, the Clear + Brilliant pélo™ laser, offers personalized results with groundbreaking laser hair removal [LHR] technology to make it fast and simple with minimal pain for anyone to get rid of unwanted hair.
The Clear + Brilliant pélo™ laser provides a highly effective treatment in a short amount of time due to its innovative linear scanning technology and the largest treatment window in the market. A full back takes only 8-12 minutes, and full legs take about 36 minutes. After 5-6 treatments, patients can see the results they want, and still have money in their pocket for the long run.
Each treatment can be customized depending on the individual's needs, and patient comfort is enhanced by minimizing pain on contact through a sapphire glass handpiece that quickly chills to 0°C. So patients and physicians can rest easy that their individual needs are met.
To view the multimedia release go to:
http://www.multivu.com/players/English/7621831-clear-brilliant-pelo-laser-hair-removal/
Debt is a buzzword for politicians, a burden for students, a necessity for most homeowners and a reality for 70 percent of Americans.
But despite this fact, 30 percent of those in debt have no plan to pay it off, according to a recent survey conducted by Fifth Third Bank (NASDAQ: FITB).
Fifth Third commissioned the national survey to examine the financial beliefs and behaviors of American adults. The results provided a snapshot of our nation’s financial literacy, with 82 percent of respondents citing financial independence as a goal in their lives. The survey also revealed how the three largest generations in America differ in their understanding and management of savings, budgeting, retirement planning and credit.
“At Fifth Third, we were curious to discover how knowledgeable Americans are about their personal finances,” said Jada Grandy, senior vice president and Community Reinvestment Act strategies director, Fifth Third Bank. “The results of this survey give insight into financial literacy in America, as well as the needs of customers at different key stages of their lives. This knowledge arms Fifth Third with the tools to support our customers at every step on their journey to financial independence.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7723851-fifth-third-bank-life/
Drivers of vehicles with good small overlap front ratings from the Insurance Institute from Highway Safety can expect to be protected well in a frontal crash involving the left corner of the vehicle. But how would the passengers sitting next to them fare in a right-side small overlap crash? A new study shows that good protection doesn’t always extend across the front seat.
The Institute conducted 40 mph passenger-side small overlap tests on seven small SUVs with good driver-side small overlap ratings. Only one of the vehicles, the 2016 Hyundai Tucson, performed at a level corresponding to a good rating, and the others ran the gamut from poor to acceptable.
The results have prompted IIHS to consider instituting a passenger-side rating as part of its TOP SAFETY PICK criteria.
To view the multimedia release go to:
http://www.multivu.com/players/English/7856251-ad-council-embrace-refugees/
MAKE UP FOR EVER, the professional makeup line of innovative and artistic products created for professional stage artists, makeup artists and makeup enthusiasts, announces a worldwide artistic collaboration with global pop sensation CHARLI XCX and reveals its new AQUA XL EYE PENCIL campaign.
CHARLI XCX’s bold, artistic and energetic stage presence exemplifies the creative spirit of MAKE UP FOR EVER and the performance of the AQUA XL collection. In 2016, MAKE UP FOR EVER joins CHARLI XCX in all her performances and artistic creations, from her live tour to makeup artistry for her video clips. A virtuoso of words and sound, CHARLI XCX has written several international hit songs including her double platinum single, “Boom Clap,” alongside co-penning music for renowned artists; Grammy nominated “Fancy” (Iggy Azalea), triple platinum selling “I Love It” (Icona Pop) and “Same Old Love” (Selena Gomez).
The AQUA line, upon which performers and their makeup artists have long relied, has become AQUA XL, taking the limits of makeup performance to new levels. MAKE UP FOR EVER is revamping one of its iconic products with a new high-performance formula: AQUA XL EYE PENCIL, the first of the AQUA XL line and specially designed for performers’ needs. AQUA XL EYE PENCIL are stage-proof and offer flawless makeup results, incredible stay-on power and high color intensity. As comfortable as it is easy to apply, the AQUA XL EYE PENCIL’s long wear waterproof formula is resistant to all stage conditions and perfect for real life-use.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7792251-make-up-for-ever-teams-up-with-charli-xcx/
According to a National Safety Council poll released today, one in four Americans personally knows someone who has overdosed or died from an opioid overdose, knows someone who has become addicted to opioids, or has become addicted themselves. In response to the survey results – and a recommendation from the President’s Commission for Combating Drug Addiction and the Opioid Crisis – the National Safety Council is launching a provocative nationwide public education campaign that literally puts a face on the opioid epidemic. Stericycle is the Council’s exclusive disposal partner on the campaign.
To view the multimedia release go to:
https://www.multivu.com/players/English/8207151-national-safety-council-stop-everyday-killers-opioids/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
The United Nations World Tourism Organization (UNWTO) recently released its list of the World’s Top 15 Model Cities for Best Practices in Tourism. Hangzhou, China was included in the list for its innovative efforts in the protection and development of as well as continuous investment in the city’s historical and cultural resources.
In December 2016, UNWTO created an award recognizing the 15 cities worldwide considered by the organization as examples to emulate when it come to the adoption of best practices in tourism, among its 193 member countries. UNWTO plans to expand the best practices applied by the winners in other global destination cities. UNWTO selected 15 winners based on the results of a survey and a performance evaluation program conducted by a panel of judges at a special evaluation meeting held in September 2017.
To view the multimedia release go to:
https://www.multivu.com/players/English/8243851-hangzhou-china-top-15-cities-best-practices-tourism/
CPhI Worldwide, organised by UBM EMEA, formally launches a new partnership with international charity Global Angels, to help promote its efforts and encourage support from the pharmaceutical industry.
The goal is to harness CPhI’s global reach to actively deliver support and funds from inside the pharma industry to Global Angels – a charity that partners with innovative projects to deliver tangible, life saving results in developing countries.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7522851-cphi-agreement-global-angels/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Monster (NYSE: MWW), a global leader in connecting people to jobs, and Brandwatch, the leading social intelligence company, today announced the results of a year-long social media study of more than 1.1 million tweets in the United States analyzing exactly who, what, when, where and why people take to Twitter to discuss how they feel about their jobs.
“It’s certainly not just the weather nor differences in temperament that drove the disparity between people in the east hating their jobs and people in the west loving them,” said Joanie Courtney, Senior Vice President, Global Market Insights at Monster. “Job satisfaction is an often fluid, temporary sensation, and social channels deliver people the opportunity to express those sentiments with greater ease than ever before. The results indicate an opportunity for companies to focus on embracing existing talent to move the ‘love-hate needle,’ as well as those Tweeting to translate their skills for new opportunities to find something better.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7470451-monster-brandwatch-social-media-study/
Third Box, a new resource for the unsure women in an unintended pregnancy, today announced results of a recent survey demonstrating that despite the current polarizing two-box political approaches, one in four women in unintended pregnancies are unsure of what to do. This data corresponds with the organization’s expansion of its reach to women in California regions, and its footprint across the country providing free medical and emotional care, in a space apart from ideology or politics, with no bias toward outcome.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7339251-third-box-sponsored-study-women-in-unintended-pregnancies-uncertain-national-expansion-campaign/
